Results 131 to 140 of about 11,603 (233)

P3700Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary PCI in acute myocardial infarction of anterior location [PDF]

, 2017
F. J. Morales Ponce, F.J. Lozano Cid, P. Martinez Romero, P. González Pérez, J.A. Sánchez Brotons, I. Díaz Torres, Eduardo Martínez de Morentín, I. Perez Lopez, Francisco Javier Camacho Jurado, R González, P.L. Martinez Garcia, C. Collado Moreno, Sánchez Turrión, Philippe Matéo, Ana Serrador   +14 more
openalex   +1 more source

PLATELET ANTIAGGREGANTS: MECHANISMS OF ACTION AND USE ASOCIED RISKS

Vitae, 2009
Cardiovascular diseases are the main cause of death in the world. Next to efforts to reduce the cardiovascular risk factors, several drugs are resorted to decrease morbimortality associated to these diseases: antihypertensive, antidiabetic, hypolipemiant
Iván F. PALOMO G, Constanza I. TORRES U., Rodrigo E. MOORE-Carrasco., Marcelo A. ALARCÓN L., Patricio J. MARAGAÑO L.   +4 more
doaj  

CD2: ABCIXIMAB IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY: A MULTICENTER OBSERVATIONAL STUDY

, 1999
Vlasses Ph, C Chen, Harlan Krumholz, Douglas Cocks, David M. McGee, D. B. Morton   +5 more
openalex   +1 more source

Benefits of abciximab for patients with ischemic stroke [PDF]

, 2005
Claire Braybrook
openalex   +1 more source

Abciximab (ReoPro) Dosing Strategy for the Management of Acute Intraprocedural Thromboembolic Complications during Pipeline Flow Diversion Treatment of Intracranial Aneurysms [PDF]

, 2018
Li-Mei Lin, Bowen Jiang, Jessica K Campos, Narlin Beaty, Matthew T. Bender, Rafael J. Tamargo, Judy Huang, Geoffrey P. Colby, Alexander L. Coon   +8 more
openalex   +1 more source

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos.

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2012
Los inhibidores de los receptores IIb/IIIa, un nuevo grupo de antiagregantes plaquetarios, son potentes bloqueadores del receptor que media la agregación plaquetaria y de ese modo bloquean la vía final común de la formación del trombo plaquetario.
Fidel Manuel Cáceres Lóriga, Horacio Pérez López   +1 more
doaj  

Acute Profound Thrombocytopenia Secondary to Local Abciximab Infusion [PDF]

, 2012
Matthew N. Peters, Christopher Press, John Moscona, Rashad H. Khazi Syed, Morgan J. Katz, Alison A Egan, Mohannad Bisharat, Vikram S. Nijjar, Asif Anwar   +8 more
openalex   +1 more source

Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention [PDF]

, 2017
Todd Golden, Sehem Ghazala, Rita Wadeea, Shilpa Junna   +3 more
openalex   +1 more source

Adverse Drug Effect Profiles of Gp2b/3a Inhibitors: A Comparative Review of the Last Two Decades. [PDF]

Cureus, 2023
Hasan N, Jauregui W, Zubair M, Pushparajan VK, Carson BJ, Attaluri DM, Dixon D, Jaisinghani A, Chuecos A, Ravichandran D.   +9 more
europepmc   +1 more source

Are tirofiban and abciximab identical in efficacy? [PDF]

, 2005
Fahim Haider Jafary
openalex   +1 more source